STERIS plc — Director's Dealing 2019

Mar 28, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STERIS Ltd (STE)
CIK: 0001757898
Period of Report: 2019-03-28

Reporting Person: Tamaro Renato (V.P. & Corporate Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-28	Ordinary Shares	A	4251	—	Acquired	4251	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-28	Employee Stock Option (right to buy)	$66.15	A	600	Acquired	2025-05-28	Ordinary Shares (600)	Direct
2019-03-28	Employee Stock Option (right to buy)	$69.72	A	596	Acquired	2026-06-01	Ordinary Shares (596)	Direct
2019-03-28	Employee Stock Option (right to buy)	$77.07	A	600	Acquired	2027-05-30	Ordinary Shares (600)	Direct
2019-03-28	Employee Stock Option (right to buy)	$114.22	A	2872	Acquired	2028-05-31	Ordinary Shares (2872)	Direct

Footnotes

F1: 2,396 of these ordinary shares are restricted. The restrictions on the ordinary shares lapse as follows: 500 on May 28, 2019; 600 on October 1, 2019; 400 on June 1, 2020; 412 on June 1, 2021 and 484 on May 31, 2022.

F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.

F3: This option becomes exercisable as follows: 150 on May 31, 2016, 150 on May 30, 2017, 150 on May 29, 2018 and 150 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 600 STERIS ordinary shares for $66.15 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F4: This option becomes exercisable as follows: 149 on June 1, 2017; 149 on June 1, 2018; 149 on June 3, 2019 and 149 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 596 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F5: This option becomes exercisable as follows: 150 on May 30, 2018; 150 on May 30, 2019; 150 on June 1, 2020 and 150 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 600 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F6: This option becomes exercisable as follows: 718 on May 31, 2019; 718 on June 1, 2020; 718 on June 1, 2021 and 718 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 2,872 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option.